David Ricks, Eli Lilly CEO (David Paul Morris/Bloomberg via Getty Images)
March 1, 2023 11:54 AM ESTUpdated 01:33 PM
Pharma

Fol­low­ing the gov­ern­men­t's lead, Lil­ly caps out-of-pock­et costs for in­sulin at $35 per month

Zachary Brennan

Senior Editor

Eli Lil­ly is look­ing to get ahead of any more fed­er­al ac­tion on in­sulin prices, an­nounc­ing to­day that it will not on­ly slash its most …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

FDA vac­cine chief Pe­ter Marks pledges to stay as long as he's wel­come

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times